Imbalanced mitochondrial dynamics in human PD and α-synuclein mouse brains

Imbalanced mitochondrial dynamics in human PD and α-synuclein mouse brains

Emerging studies have shown that dysregulation in mitochondrial dynamics has a major negative impact on mitochondria. Partial genetic and pharmacological inhibition of the mitochondrial fission dynamin-related protein 1 (DRP1) has been demonstrated to be beneficial in models of neurodegenerative dis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Harry J. Brown, Rebecca Z. Fan, Riley Bell, Said S. Salehe, Carlos Martínez Martínez, Yanhao Lai, Kim Tieu
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Neurobiology of Disease
Subjects:	Parkinson's disease α-synuclein Dynamin-related protein 1 Mitochondrial dynamics Protein aggregation Neurodegeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996125001925
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability
by: Elena A. Ostrakhovitch, et al.
Published: (2025-05-01)

Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
by: Dylan J. Dues, et al.
Published: (2025-06-01)

From the baker to the bedside: yeast models of Parkinson's disease
by: Regina Menezes, et al.
Published: (2015-07-01)

c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation
by: Jyutia Nargish, et al.
Published: (2025-04-01)

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms
by: Lucia Lage, et al.
Published: (2025-03-01)

Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models
by: Jie Jiao, et al.
Published: (2024-11-01)

Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease
by: Lydia Shen, et al.
Published: (2024-12-01)

Serine-129 phosphorylated α-synuclein drives mitochondrial dysfunction and calcium dysregulation in Parkinson’s disease model
by: Jie Jiao, et al.
Published: (2025-03-01)

Salt-Induced Membrane-Bound Conformation of the NAC Domain of α-Synuclein Leads to Structural Polymorphism of Amyloid Fibrils
by: Ryota Imaura, et al.
Published: (2025-03-01)

A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
by: Silvia Zini, et al.
Published: (2025-09-01)

Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis
by: Amit U Joshi, et al.
Published: (2018-01-01)

α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons
by: Plamena R. Angelova, et al.
Published: (2025-10-01)

Redistribution of fragmented mitochondria ensures symmetric organelle partitioning and faithful chromosome segregation in mitotic mouse zygotes
by: Haruna Gekko, et al.
Published: (2025-08-01)

The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
by: Haoran Xiang, et al.
Published: (2025-04-01)

Mitochondrial membrane protein-associated neurodegeneration presenting with pure motor neuropathy: A rare case report and review of the literature
by: Vikas Lakhanpal, et al.
Published: (2024-05-01)

Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable
by: Rabab Al-Lahham, et al.
Published: (2025-05-01)

A splice‐switching antisense oligonucleotide targeting APP reduces accumulation of α‐synuclein in a mouse model of Parkinson's disease
by: Rijwan U. Ahammad, et al.
Published: (2025-04-01)

Aged Lewis rats exposed to low and moderate doses of rotenone are a good model for studying the process of protein aggregation and its effects upon central nervous system cell physiology
by: Michael F. Almeida, et al.

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

Impact of Drp1 Loss on Organelle Interaction, Metabolism, and Inflammation in Mouse Liver
by: Lixiang Wang, et al.
Published: (2025-05-01)

Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform
by: Martin Schuler, et al.
Published: (2025-04-01)

Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
by: Filip Fredlund, et al.
Published: (2025-04-01)

Discovery of <i>N</i>-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography
by: Haiyang Zhao, et al.
Published: (2025-07-01)

Brain network and energy imbalance in Parkinson’s disease: linking ATP reduction and α-synuclein pathology
by: Hirohisa Watanabe, et al.
Published: (2025-01-01)

Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease
by: Wenlong Zhang, et al.
Published: (2024-11-01)

Silencing of PCK1 mitigates the proliferation and migration of vascular smooth muscle cells and vascular intimal hyperplasia by suppressing STAT3/DRP1-mediated mitochondrial fission
by: Zhang Li, et al.
Published: (2024-09-01)

The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
by: Yan Chen, et al.
Published: (2025-04-01)

RETRACTED ARTICLE: Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD
by: Michiyo Iba, et al.
Published: (2022-09-01)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
by: Inga Petersen, et al.
Published: (2023-12-01)

α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease
by: Yakum B. Mingo, et al.
Published: (2025-06-01)

Exogenous prion-like proteins and their potential to trigger cognitive dysfunction
by: Jofre Seira Curto, et al.
Published: (2025-05-01)

Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-11-01)

Synthesis and preliminary biological evaluation of a novel PET tracer for α-synuclein PET imaging
by: WANG Ce, et al.
Published: (2024-10-01)

Peripherally administered TNF inhibitor is not protective against α-synuclein-induced dopaminergic neuronal death in rats
by: Josefine R. Christiansen, et al.
Published: (2025-03-01)

Inhibition of Dynamin-Related Protein 1-Dependent Mitochondrial Fission Ameliorates Apical Periodontitis by Attenuating NLRP3 Inflammasome-Mediated M1 Macrophage Polarisation
by: Yao Yang, et al.
Published: (2025-08-01)

Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease
by: Hanjiang Luo, et al.
Published: (2026-04-01)

Lactoferrin as a Candidate Multifunctional Therapeutic in Synucleinopathies
by: Caroline A. Barros, et al.
Published: (2025-04-01)

NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson’s model
by: Julian E. Alecu, et al.
Published: (2025-01-01)

A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
by: Dag Sehlin, et al.
Published: (2025-03-01)